Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen, United Kingdom: Methods and preliminary results
Identifieur interne : 004589 ( Main/Merge ); précédent : 004588; suivant : 004590Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen, United Kingdom: Methods and preliminary results
Auteurs : Kate S. M. Taylor [Royaume-Uni] ; Carl E. Counsell [Royaume-Uni] ; Clare E. Harris [Royaume-Uni] ; Joanna C. Gordon [Royaume-Uni] ; W. Cairns S. Smith [Royaume-Uni]Source :
- Movement Disorders [ 0885-3185 ] ; 2006-07.
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Cognition Disorders (diagnosis), Cognition Disorders (epidemiology), Cohort Studies, Cross-Sectional Studies, Disability Evaluation, Female, Humans, Incidence, Male, Neurodegenerative Diseases (diagnosis), Neurodegenerative Diseases (epidemiology), Neurologic Examination, Parkinson's disease, Parkinsonian Disorders (diagnosis), Parkinsonian Disorders (epidemiology), Parkinsonism, Pilot Projects, Prognosis, Quality of Life, Scotland, cohort study, incidence.
- MESH :
- geographic : Scotland.
- diagnosis : Cognition Disorders, Neurodegenerative Diseases, Parkinsonian Disorders.
- epidemiology : Cognition Disorders, Neurodegenerative Diseases, Parkinsonian Disorders.
- Aged, Aged, 80 and over, Cohort Studies, Cross-Sectional Studies, Disability Evaluation, Female, Humans, Incidence, Male, Neurologic Examination, Pilot Projects, Prognosis, Quality of Life.
Abstract
The objective of this study was to test the methods for a large study of the incidence and prognosis of Parkinson's disease and other degenerative parkinsonian disorders and provide provisional incidence figures. This was a community‐based prospective study to identify patients with newly diagnosed non–drug‐induced Parkinsonism (≥2 of tremor, rigidity, bradykinesia, postural instability) from a population of 148,600 people in Aberdeen, Scotland, over 18 months. Multiple search strategies were used to identify patients, including some population screening. Incident patients and age/sex–matched controls had assessments of impairment, disability, quality of life, mood, and cognition and are being followed up yearly. Two hundred and two people with possible parkinsonian symptoms were assessed, and 82 incident patients were identified, 50 with probable Parkinson's disease. The crude incidences of probable Parkinsonism and probable Parkinson's disease were 31.4/100,000/year (95% CI: 24.5–39.7) and 22.4/100,000/year (95% CI: 16.6–29.6), respectively. The mean age of diagnosis of Parkinson's disease was 76.1 ± 10.0 years and the incidence was greater in men. The methods were generally successful. Provisionally, we found a higher incidence of Parkinson's disease than other comparable studies, and our patients were considerably older. This may reflect better case ascertainment in the elderly. A larger study is planned. © 2006 Movement Disorder Society
Url:
DOI: 10.1002/mds.20866
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001696
- to stream Istex, to step Curation: 001696
- to stream Istex, to step Checkpoint: 001D35
- to stream PubMed, to step Corpus: 002D07
- to stream PubMed, to step Curation: 002D07
- to stream PubMed, to step Checkpoint: 002B69
- to stream Ncbi, to step Merge: 001624
- to stream Ncbi, to step Curation: 001624
- to stream Ncbi, to step Checkpoint: 001624
Links to Exploration step
ISTEX:9EFCAFFA3450B1BC0878125F995FF88CAF41AA2BLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen, United Kingdom: Methods and preliminary results</title><author><name sortKey="Taylor, Kate S M" sort="Taylor, Kate S M" uniqKey="Taylor K" first="Kate S. M." last="Taylor">Kate S. M. Taylor</name></author><author><name sortKey="Counsell, Carl E" sort="Counsell, Carl E" uniqKey="Counsell C" first="Carl E." last="Counsell">Carl E. Counsell</name></author><author><name sortKey="Harris, Clare E" sort="Harris, Clare E" uniqKey="Harris C" first="Clare E." last="Harris">Clare E. Harris</name></author><author><name sortKey="Gordon, Joanna C" sort="Gordon, Joanna C" uniqKey="Gordon J" first="Joanna C." last="Gordon">Joanna C. Gordon</name></author><author><name sortKey="Smith, W Cairns S" sort="Smith, W Cairns S" uniqKey="Smith W" first="W. Cairns S." last="Smith">W. Cairns S. Smith</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:9EFCAFFA3450B1BC0878125F995FF88CAF41AA2B</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1002/mds.20866</idno><idno type="url">https://api.istex.fr/document/9EFCAFFA3450B1BC0878125F995FF88CAF41AA2B/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001696</idno><idno type="wicri:Area/Istex/Curation">001696</idno><idno type="wicri:Area/Istex/Checkpoint">001D35</idno><idno type="wicri:doubleKey">0885-3185:2006:Taylor K:pilot:study:of</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:16570298</idno><idno type="wicri:Area/PubMed/Corpus">002D07</idno><idno type="wicri:Area/PubMed/Curation">002D07</idno><idno type="wicri:Area/PubMed/Checkpoint">002B69</idno><idno type="wicri:Area/Ncbi/Merge">001624</idno><idno type="wicri:Area/Ncbi/Curation">001624</idno><idno type="wicri:Area/Ncbi/Checkpoint">001624</idno><idno type="wicri:doubleKey">0885-3185:2006:Taylor K:pilot:study:of</idno><idno type="wicri:Area/Main/Merge">004589</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen, United Kingdom: Methods and preliminary results</title><author><name sortKey="Taylor, Kate S M" sort="Taylor, Kate S M" uniqKey="Taylor K" first="Kate S. M." last="Taylor">Kate S. M. Taylor</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen</wicri:regionArea><wicri:noRegion>Aberdeen</wicri:noRegion></affiliation></author><author><name sortKey="Counsell, Carl E" sort="Counsell, Carl E" uniqKey="Counsell C" first="Carl E." last="Counsell">Carl E. Counsell</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen</wicri:regionArea><wicri:noRegion>Aberdeen</wicri:noRegion></affiliation></author><author><name sortKey="Harris, Clare E" sort="Harris, Clare E" uniqKey="Harris C" first="Clare E." last="Harris">Clare E. Harris</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen</wicri:regionArea><wicri:noRegion>Aberdeen</wicri:noRegion></affiliation></author><author><name sortKey="Gordon, Joanna C" sort="Gordon, Joanna C" uniqKey="Gordon J" first="Joanna C." last="Gordon">Joanna C. Gordon</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen</wicri:regionArea><wicri:noRegion>Aberdeen</wicri:noRegion></affiliation></author><author><name sortKey="Smith, W Cairns S" sort="Smith, W Cairns S" uniqKey="Smith W" first="W. Cairns S." last="Smith">W. Cairns S. Smith</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Public Health, University of Aberdeen, Aberdeen</wicri:regionArea><wicri:noRegion>Aberdeen</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2006-07">2006-07</date><biblScope unit="vol">21</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="976">976</biblScope><biblScope unit="page" to="982">982</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">9EFCAFFA3450B1BC0878125F995FF88CAF41AA2B</idno><idno type="DOI">10.1002/mds.20866</idno><idno type="ArticleID">MDS20866</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Cognition Disorders (diagnosis)</term><term>Cognition Disorders (epidemiology)</term><term>Cohort Studies</term><term>Cross-Sectional Studies</term><term>Disability Evaluation</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Neurodegenerative Diseases (diagnosis)</term><term>Neurodegenerative Diseases (epidemiology)</term><term>Neurologic Examination</term><term>Parkinson's disease</term><term>Parkinsonian Disorders (diagnosis)</term><term>Parkinsonian Disorders (epidemiology)</term><term>Parkinsonism</term><term>Pilot Projects</term><term>Prognosis</term><term>Quality of Life</term><term>Scotland</term><term>cohort study</term><term>incidence</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Scotland</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Cognition Disorders</term><term>Neurodegenerative Diseases</term><term>Parkinsonian Disorders</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Cognition Disorders</term><term>Neurodegenerative Diseases</term><term>Parkinsonian Disorders</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Cohort Studies</term><term>Cross-Sectional Studies</term><term>Disability Evaluation</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Neurologic Examination</term><term>Pilot Projects</term><term>Prognosis</term><term>Quality of Life</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The objective of this study was to test the methods for a large study of the incidence and prognosis of Parkinson's disease and other degenerative parkinsonian disorders and provide provisional incidence figures. This was a community‐based prospective study to identify patients with newly diagnosed non–drug‐induced Parkinsonism (≥2 of tremor, rigidity, bradykinesia, postural instability) from a population of 148,600 people in Aberdeen, Scotland, over 18 months. Multiple search strategies were used to identify patients, including some population screening. Incident patients and age/sex–matched controls had assessments of impairment, disability, quality of life, mood, and cognition and are being followed up yearly. Two hundred and two people with possible parkinsonian symptoms were assessed, and 82 incident patients were identified, 50 with probable Parkinson's disease. The crude incidences of probable Parkinsonism and probable Parkinson's disease were 31.4/100,000/year (95% CI: 24.5–39.7) and 22.4/100,000/year (95% CI: 16.6–29.6), respectively. The mean age of diagnosis of Parkinson's disease was 76.1 ± 10.0 years and the incidence was greater in men. The methods were generally successful. Provisionally, we found a higher incidence of Parkinson's disease than other comparable studies, and our patients were considerably older. This may reflect better case ascertainment in the elderly. A larger study is planned. © 2006 Movement Disorder Society</div></front></TEI><double doi="10.1002/mds.20866"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen, United Kingdom: Methods and preliminary results</title><author><name sortKey="Taylor, Kate S M" sort="Taylor, Kate S M" uniqKey="Taylor K" first="Kate S. M." last="Taylor">Kate S. M. Taylor</name></author><author><name sortKey="Counsell, Carl E" sort="Counsell, Carl E" uniqKey="Counsell C" first="Carl E." last="Counsell">Carl E. Counsell</name></author><author><name sortKey="Harris, Clare E" sort="Harris, Clare E" uniqKey="Harris C" first="Clare E." last="Harris">Clare E. Harris</name></author><author><name sortKey="Gordon, Joanna C" sort="Gordon, Joanna C" uniqKey="Gordon J" first="Joanna C." last="Gordon">Joanna C. Gordon</name></author><author><name sortKey="Smith, W Cairns S" sort="Smith, W Cairns S" uniqKey="Smith W" first="W. Cairns S." last="Smith">W. Cairns S. Smith</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:9EFCAFFA3450B1BC0878125F995FF88CAF41AA2B</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1002/mds.20866</idno><idno type="url">https://api.istex.fr/document/9EFCAFFA3450B1BC0878125F995FF88CAF41AA2B/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001696</idno><idno type="wicri:Area/Istex/Curation">001696</idno><idno type="wicri:Area/Istex/Checkpoint">001D35</idno><idno type="wicri:doubleKey">0885-3185:2006:Taylor K:pilot:study:of</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen, United Kingdom: Methods and preliminary results</title><author><name sortKey="Taylor, Kate S M" sort="Taylor, Kate S M" uniqKey="Taylor K" first="Kate S. M." last="Taylor">Kate S. M. Taylor</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen</wicri:regionArea><wicri:noRegion>Aberdeen</wicri:noRegion></affiliation></author><author><name sortKey="Counsell, Carl E" sort="Counsell, Carl E" uniqKey="Counsell C" first="Carl E." last="Counsell">Carl E. Counsell</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen</wicri:regionArea><wicri:noRegion>Aberdeen</wicri:noRegion></affiliation></author><author><name sortKey="Harris, Clare E" sort="Harris, Clare E" uniqKey="Harris C" first="Clare E." last="Harris">Clare E. Harris</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen</wicri:regionArea><wicri:noRegion>Aberdeen</wicri:noRegion></affiliation></author><author><name sortKey="Gordon, Joanna C" sort="Gordon, Joanna C" uniqKey="Gordon J" first="Joanna C." last="Gordon">Joanna C. Gordon</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen</wicri:regionArea><wicri:noRegion>Aberdeen</wicri:noRegion></affiliation></author><author><name sortKey="Smith, W Cairns S" sort="Smith, W Cairns S" uniqKey="Smith W" first="W. Cairns S." last="Smith">W. Cairns S. Smith</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Public Health, University of Aberdeen, Aberdeen</wicri:regionArea><wicri:noRegion>Aberdeen</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2006-07">2006-07</date><biblScope unit="vol">21</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="976">976</biblScope><biblScope unit="page" to="982">982</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">9EFCAFFA3450B1BC0878125F995FF88CAF41AA2B</idno><idno type="DOI">10.1002/mds.20866</idno><idno type="ArticleID">MDS20866</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>Parkinsonism</term><term>cohort study</term><term>incidence</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The objective of this study was to test the methods for a large study of the incidence and prognosis of Parkinson's disease and other degenerative parkinsonian disorders and provide provisional incidence figures. This was a community‐based prospective study to identify patients with newly diagnosed non–drug‐induced Parkinsonism (≥2 of tremor, rigidity, bradykinesia, postural instability) from a population of 148,600 people in Aberdeen, Scotland, over 18 months. Multiple search strategies were used to identify patients, including some population screening. Incident patients and age/sex–matched controls had assessments of impairment, disability, quality of life, mood, and cognition and are being followed up yearly. Two hundred and two people with possible parkinsonian symptoms were assessed, and 82 incident patients were identified, 50 with probable Parkinson's disease. The crude incidences of probable Parkinsonism and probable Parkinson's disease were 31.4/100,000/year (95% CI: 24.5–39.7) and 22.4/100,000/year (95% CI: 16.6–29.6), respectively. The mean age of diagnosis of Parkinson's disease was 76.1 ± 10.0 years and the incidence was greater in men. The methods were generally successful. Provisionally, we found a higher incidence of Parkinson's disease than other comparable studies, and our patients were considerably older. This may reflect better case ascertainment in the elderly. A larger study is planned. © 2006 Movement Disorder Society</div></front></TEI></ISTEX><PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen, United Kingdom: methods and preliminary results.</title><author><name sortKey="Taylor, Kate S M" sort="Taylor, Kate S M" uniqKey="Taylor K" first="Kate S M" last="Taylor">Kate S M. Taylor</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen</wicri:regionArea><wicri:noRegion>Aberdeen</wicri:noRegion></affiliation></author><author><name sortKey="Counsell, Carl E" sort="Counsell, Carl E" uniqKey="Counsell C" first="Carl E" last="Counsell">Carl E. Counsell</name></author><author><name sortKey="Harris, Clare E" sort="Harris, Clare E" uniqKey="Harris C" first="Clare E" last="Harris">Clare E. Harris</name></author><author><name sortKey="Gordon, Joanna C" sort="Gordon, Joanna C" uniqKey="Gordon J" first="Joanna C" last="Gordon">Joanna C. Gordon</name></author><author><name sortKey="Smith, W Cairns S" sort="Smith, W Cairns S" uniqKey="Smith W" first="W Cairns S" last="Smith">W Cairns S. Smith</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2006">2006</date><idno type="doi">10.1002/mds.20866</idno><idno type="RBID">pubmed:16570298</idno><idno type="pmid">16570298</idno><idno type="wicri:Area/PubMed/Corpus">002D07</idno><idno type="wicri:Area/PubMed/Curation">002D07</idno><idno type="wicri:Area/PubMed/Checkpoint">002B69</idno><idno type="wicri:Area/Ncbi/Merge">001624</idno><idno type="wicri:Area/Ncbi/Curation">001624</idno><idno type="wicri:Area/Ncbi/Checkpoint">001624</idno><idno type="wicri:doubleKey">0885-3185:2006:Taylor K:pilot:study:of</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen, United Kingdom: methods and preliminary results.</title><author><name sortKey="Taylor, Kate S M" sort="Taylor, Kate S M" uniqKey="Taylor K" first="Kate S M" last="Taylor">Kate S M. Taylor</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen</wicri:regionArea><wicri:noRegion>Aberdeen</wicri:noRegion></affiliation></author><author><name sortKey="Counsell, Carl E" sort="Counsell, Carl E" uniqKey="Counsell C" first="Carl E" last="Counsell">Carl E. Counsell</name></author><author><name sortKey="Harris, Clare E" sort="Harris, Clare E" uniqKey="Harris C" first="Clare E" last="Harris">Clare E. Harris</name></author><author><name sortKey="Gordon, Joanna C" sort="Gordon, Joanna C" uniqKey="Gordon J" first="Joanna C" last="Gordon">Joanna C. Gordon</name></author><author><name sortKey="Smith, W Cairns S" sort="Smith, W Cairns S" uniqKey="Smith W" first="W Cairns S" last="Smith">W Cairns S. Smith</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="ISSN">0885-3185</idno><imprint><date when="2006" type="published">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Cognition Disorders (diagnosis)</term><term>Cognition Disorders (epidemiology)</term><term>Cohort Studies</term><term>Cross-Sectional Studies</term><term>Disability Evaluation</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Neurodegenerative Diseases (diagnosis)</term><term>Neurodegenerative Diseases (epidemiology)</term><term>Neurologic Examination</term><term>Parkinsonian Disorders (diagnosis)</term><term>Parkinsonian Disorders (epidemiology)</term><term>Pilot Projects</term><term>Prognosis</term><term>Quality of Life</term><term>Scotland</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Scotland</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Cognition Disorders</term><term>Neurodegenerative Diseases</term><term>Parkinsonian Disorders</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Cognition Disorders</term><term>Neurodegenerative Diseases</term><term>Parkinsonian Disorders</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Cohort Studies</term><term>Cross-Sectional Studies</term><term>Disability Evaluation</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Neurologic Examination</term><term>Pilot Projects</term><term>Prognosis</term><term>Quality of Life</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The objective of this study was to test the methods for a large study of the incidence and prognosis of Parkinson's disease and other degenerative parkinsonian disorders and provide provisional incidence figures. This was a community-based prospective study to identify patients with newly diagnosed non-drug-induced Parkinsonism (>or=2 of tremor, rigidity, bradykinesia, postural instability) from a population of 148,600 people in Aberdeen, Scotland, over 18 months. Multiple search strategies were used to identify patients, including some population screening. Incident patients and age/sex-matched controls had assessments of impairment, disability, quality of life, mood, and cognition and are being followed up yearly. Two hundred and two people with possible parkinsonian symptoms were assessed, and 82 incident patients were identified, 50 with probable Parkinson's disease. The crude incidences of probable Parkinsonism and probable Parkinson's disease were 31.4/100,000/year (95% CI: 24.5-39.7) and 22.4/100,000/year (95% CI: 16.6-29.6), respectively. The mean age of diagnosis of Parkinson's disease was 76.1 +/- 10.0 years and the incidence was greater in men. The methods were generally successful. Provisionally, we found a higher incidence of Parkinson's disease than other comparable studies, and our patients were considerably older. This may reflect better case ascertainment in the elderly. A larger study is planned.</div></front></TEI></PubMed></double></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004589 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 004589 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Merge
|type= RBID
|clé= ISTEX:9EFCAFFA3450B1BC0878125F995FF88CAF41AA2B
|texte= Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen, United Kingdom: Methods and preliminary results
}}
| This area was generated with Dilib version V0.6.23. |  |